Skip to main content
. 2018 Oct 19;97(42):e12806. doi: 10.1097/MD.0000000000012806

Figure 3.

Figure 3

A. ROC curve analysis of PSA, PCA3, hK2, and miR-141 in 100 patients. B. ROC curve analysis of PSA, PCA3, hK2, and miR-141 in patients without bone metastases. C. ROC curve analysis of PSA, PCA3, hK2, and miR-141 in patients with PSA between 4 to 10 ng/mL. hK2 = human glandular kallikrein 2, PCA3 = prostate cancer gene 3, PSA = prostate specific antigen, ROC = receiver operating characteristic.